Article Text

Download PDFPDF

Original article
‘S’-shaped curve: modelling trends in smoking prevalence, uptake and cessation in Great Britain from 1973 to 2016
  1. Emma Victoria Beard1,
  2. Robert West1,
  3. Martin Jarvis1,
  4. Susan Michie2,
  5. Jamie Brown1
  1. 1 Department of Behavioural Science and Health, University College London, London, UK
  2. 2 Research Department of Clinical, Educational and Health Psychology, University College London, Sheffield, UK
  1. Correspondence to Emma Victoria Beard, Epidemiology and Public Health, UCL, London WC1E 6BT, UK; e.beard{at}ucl.ac.uk

Footnotes

  • Contributors All authors designed the study. MJ collected the data and EVB wrote the first draft and conducted the analyses. All authors commented on this draft and contributed to the final version. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. EVB is study guarantor.

  • Funding EVB and JB salaries are funded by a programme grant from Cancer Research UK (CRUK; C1417/A22962). EVB also receives support from NIHR School for Public Health Research.

  • Disclaimer No funders had any involvement in the design of the study, the analysis or interpretation of the data, the writing of the report or the decision to submit the paper for publication.

  • Competing interests JB and EVB have received unrestricted research funding from Pfizer, who manufacture smoking cessation medications. RW undertakes consultancy and research for and receives travel funds and hospitality from manufacturers of smoking cessation medications.

  • Patient consent for publication Not required.

  • Ethics approval This was a secondary data analysis of population surveys which were originally granted ethical approval. We received all data deidentified.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors All authors designed the study. MJ collected the data and EVB wrote the first draft and conducted the analyses. All authors commented on this draft and contributed to the final version. All authors had full access to all of the data (including statistical reports and tables) in the study and can take responsibility for the integrity of the data and the accuracy of the data analysis. EVB is study guarantor.

  • Funding EVB and JB salaries are funded by a programme grant from Cancer Research UK (CRUK; C1417/A22962). EVB also receives support from NIHR School for Public Health Research.

  • Disclaimer No funders had any involvement in the design of the study, the analysis or interpretation of the data, the writing of the report or the decision to submit the paper for publication.

  • Competing interests JB and EVB have received unrestricted research funding from Pfizer, who manufacture smoking cessation medications. RW undertakes consultancy and research for and receives travel funds and hospitality from manufacturers of smoking cessation medications.

  • Patient consent for publication Not required.

  • Ethics approval This was a secondary data analysis of population surveys which were originally granted ethical approval. We received all data deidentified.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles